Skip to content
Companies

seqWell

DNA library prep for high-throughput sequencing

Raised to date

$3.1M

of $3.6M offered across 2 Form D filings

Still open
$424K
Investors
1
Last filed
Feb 6, 2025

About

seqWell Inc. is a biotechnology company dedicated to advancing the efficiency and accuracy of DNA/RNA library preparation workflows for next-generation sequencing (NGS). By pioneering innovative solutions, seqWell streamlines complex processes, making genetic testing more accessible and reliable for laboratories worldwide.

seqWell stands out for its ability to condense multiple sequencing preparation steps into singular, efficient processes, significantly reducing preparation time and error rates in genetic testing workflows.

Funding

$3.5M round, first sold Sep 2024$3.1M sold$424K still open20252026
Now
  • EquityFiled Feb 6, 2025Form D
    $3.1M/ $3.5M
  • Security to be acquiredFiled Jan 27, 2025Form D
    $12K/ $12K

Product

ExpressPlex™

Library Preparation Solution

ExpressPlex™ is a revolutionary product from seqWell that simplifies the traditional library preparation workflows for sequencing, integrating multiple procedural steps into a single streamlined process. This product enhances quality control measures and supports a wide range of sequencing applications with improved efficiency and reduced complexity.

  • Simplified library prep
  • Combines 3-4 steps into one process
  • Enhanced quality control

Built for

Genomic research laboratories

People on file